Comprehensive 980-page analysis of the French microbiology testing market.
Major issues pertaining to the French microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in French hospitals, blood banks and commercial laboratories.
Instrumentation technologies and feature comparison of leading analyzers.
Sales and market shares of leading suppliers.
Emerging diagnostic technologies and their potential market applications.
Product development opportunities.
Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Business opportunities and strategic recommendations for suppliers.
Contains 980 pages and 160 tables
Table of Contents
Table of Contents
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
Structure and Composition
Classification
Origin of AIDS
Animal Lentivirus Systems
Virus Receptos
HIV Infections in Humans
Pathogenesis & Pathology: Overview of HIV Infection Course
CD4T Lymphocytes and Memory Cells
Monocytes and Macrophages
Lymphoid Organs
Neural Cells
Viral Coinfections
Clinical Findings
Plasma Viral Load
Pediatric AIDS
Neurologic Disease
Opportunistic Infections
Cancer
Immunity
Virus Isolation
Serology
Detection of Viral Nucleic Acid and Antigens
Infectivity
Epidemiology
Worldwide Spread of AIDS
United States
Routes of Transmission
b. Diagnostic Tests
Laboratory Diagnosis
Enzyme Immunoassay Interpretation
Specific, Sensitivity, and Predictive Value of Enzyme Immunoassays
Competition Assays
Western Blot Technique
Immuno-Fluorescence Assay (IFA)
Radioimmunoprecipitation
HIV-1/HIV-2 Combination Testing
Methods of HIV-Antigen Detection
Antigen Assays and Blood Screening
Urine Tests
Immunopathogenic Mechanism of HIV Infection
DNA Probes
Overview
Quantitative Polymerase Chain Reaction
In Situ PCR
Needed Improvements
Viral Load/Drug Resistance Testing
Genotype and Phenotype Testing
Blood Banking Consideration
c. Vaccines and Drugs
Antiviral Drugs
Vaccines Against HIV
Transmission of HIV in Blood Products
HIV Transmission in Transplant and Artificial Insemination Recipients
2. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Campylobacter
a. Background
b. Diagnostic Tests
0 Identification from Culture
c. Vaccines and Drugs
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
Chlamydia Psittaci
Chlamydia Pneumoniae
Chlamydia Trachomatis
b. Diagnostic Tests
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
Pediatric Infections
Epidemiology
b. Diagnostic Tests
Counterimmunoelectrophoresis
Fluorescent-Antibody Assays
Poloymerase Chain Reactions
c. Drugs and Vaccines
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
Herpangina
Hand-foot-and-mouth syndrome
Hepidemic Conjuctivitis
Pharingitis
Epidemic Pleurodynia
Myodarditis,Pericarditis
Overwhelming Infection of the Newborn
Acute Aseptic Meningitis
Undifferentiated Febrile Illness
Fever with upper respiratory infection
Encephalitis
Asymptomatic Infection
b. Diagnostic Tests
c. Vaccines and Drugs
18. Creutzfeldt-Jakob's Disease
a. Background
Blood Transmission
b. Diagnostic Tests
Major Commercial and Academic Players
Bayer
Disease Sciences/Bio Tec Global
Imperial College of Medicine
Ortho-Clinical Diagnostics
Pall
ProMetic Life Sciences
Proteome Sciences/Idexx
Q-One Biotech
Serono
U.S. Agricultural Research Service
c. Vaccines
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
Histologic
Laboratory Parasitology
Serodiagnosis
c. Vaccines and Drugs
20. Cyclospora Cayetanensis
a. Background
Asymptomatic Infection
Diarrhea in Immunocompetent Persons
Diarrhea in Immunocompromisedersons
b. Diagnostic Tests
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
Chorioretinitis
Gastrointestinal
Central Nervous System Disease
b. Diagnostic Tests
c. Vaccines and Drugs
22. Ebola Virus
a. Background
Epidemiology
Hemorrhagic Fever
b. Diagnostic Tests
c. Vaccines and Drugs
23. E. Coli
a. Background
Role of Escherichia Coli in Causing Diarrhea
EPEC
ETEC
EIEC
EHEC
b. Diagnostic Tests
c. Vaccines and Drugs
24. EchoVirus
a. Background
Acute Aseptic Miningitisis
Encephalitis
Exanthems
Respiratory Disease
Myope;ricarditis
Neonatal Infections
b. Diagnostic Tests
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
Viral Isolation and Identification
Antibody Tests
c. Vaccines and Drugs
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
Life Cycle and Morphology
Morphology of Trophozoites
Clinical Disease
b. Diagnostic Tests
c. Vaccines and Drugs
29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
Identification of the Agent
Transmission
Other Rodent Hantaviruses
Distribution
Hantavirus Diseases
Epidemiology
Addendum in Proof-Northeastern Connection
Previously Unknown Pathogens
Cases Nationwide
b. Diagnostic Tests
An Immunohistochemistry Approach
Hantavirus Rapid Diagnostic Test
ELISA Diagnosis of Hantavirus Pulmonary Syndrome
IgG ELISA
IgM Capture ELISA
c. Vaccines and Drugs
32. Helicobacter Pylori
a. Background
Pathogenesis
Role in Peptic Ulcer Disease
Role in Gastric Cancer
Nonulcer Dyspepsia
b. Diagnostic Tests
c. Vaccines and Drugs
Specific Therapeutic Regimens
Who Should Be Treated?
Participants in Controlled Clinical Trials
Patients with Refractory Peptic Ulcer
Patients with Refractory NUD
Patients in High-Risk Groups for Gastric Cancer
33. Hepatitis
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
Classification
Transmission of Infection
Occupational Hazards
Acute Hepatitis
Diagnosis of Acute Infection
Chronic Hepatitis
HCV and Other Chronic Liver Diseases
Alcoholic Liver Disease
Hepatitis B Coinfection
Cirrhosis and Hepatocellular Carcinoma
Diagnostic Tests
Possible Indications for HCV RNA Testing
Conclusions and Future Direction
e. Hepatitis D
Historical Perspective
Epidemiology
HBV-HDV "Coinfection" vs. "Superinfection"
Methods of Detecting HDV
Prevention
f. Hepatitis E
Background
Prevalence of the Disease
Diagnostic Tests
Epidemiologic Serosurveys
Serologic Cross-Reactivity
g. Hepatitis G
Vaccines and Drugs
34. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
HIV-6 Infections
b. Diagnostic Tests
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
38. Lyme Disease
a. Background
Clinical Description
Clinical Case Definition
Laboratory Criteria for Diagnosis
Case Classification
b. Diagnostic Tests
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
Potential Diagnositic Problems with Positive Patients from Non-endemic
Areas
Patient
Laboratory
Physician
c. Vaccines and Drugs
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Development of Polysaccharide Vaccines
Quadrivalent Vaccine Development
Meningococcal A.C.Y. & W-135 Vaccines
Efficacy of Group C Vaccine
Efficacy of Group A Vaccine
Combinations of Group A and C Vaccines
Group B Efficacy Trials
Future Direction
43. Microsporidium
a. Background
Prevalence and Geographic Distribution
Sources of Human Infection and Transmission
b. Diagnostic Tests
Light Microscopic Examination of Stool Specimens By Chromotrope Staining
Stool Concentration Methods
Chemofluorescent Agents
Giemsa Staining of Stool Specimens
Cytologic Diagnosis
Histologic Examination
Electron Microscopy
Examination of Bodily Fluids
Examination of Tissue Sections
Immunofluorescence Detection Procedures
Serology
Cell Culture
Approach to Diagnosis
Evaluation of Patients with Presumptive Intestinal Microsporidiosis
Evaluation of Patients with Presumptive Ocular Microsporidiosis
c. Vaccines and Drugs
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Efficacy of Vaccination
Future Issues
46. Mycoplasma
a. Background
Ureaplasma Urealyticum & Mycoplasma Hominis
b. Diagnostic Tests
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
HPV in Cancer
Cervical Neoplasm
b. Diagnostic Tests
c. Vaccines and Drugs
Prevention
48. Parvovirus B19
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
Virulence Factors
b. Diagnostic Tests
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
56. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Developing Countries
Elimination and Eradication of Measles
New Developments
57. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
The Genus Taphylococcus
b. Diagnostic Tests
c. Vaccines and Drugs
Prevention
61. Streptococci
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Group A Streptococci
Group B Streptococci
62. Syphilis
a. Background
b. Diagnostic Tests
Biopsy
Rabbit Infectivity Testing
Other Diagnostic Modalities
c. Vaccines and Drugs
Syphilis and HIV Infection
Syphilis As a Cofactor for HIV Transmission
Basic Science Issues
63. Toxoplasmosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
Microscopic Characteristics
Cultural Characteristics
Detection of Antibodies
Skin Tests
MDRTB
c. Vaccines and Drugs
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
Clinical Syndromes
b. Diagnostic Tests
c. Vaccines and Drugs
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review and Market Needs
Abbott AxSYM
Abbott IMx/IMx Select
Anagen AN2000/AuraFlex
Beckman Coulter Access
BioChem Pharma/SR1
BioMerieux/Vitek Vidas
Biotrol System 7000
Chiron ACS: Centaur
Chiron ACS: 180
J&J Diagnostics/Amersham Amerlite
J&J Diagnostics Vitros ECi
Olympus PK310
Roche Cobas Core
Roche Elecsys 1010/2010
Roche ES 22
Roche ES 33
Roche ES 300/300AL
Siemens ELISA Processor II/III
Siemens Immuno 1
Siemens/Opus/Plus/Magnum
Siemens Stratus
Tosoh AIA-1200/1200DX/NexIA/600
Wallac/Pharmacia Delfia
C. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Robotics
Temperature Cyclers
PCR Variations
Immuno-PCR
QC-PCR
DAP-PCR
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Nucleic-Acid Sequence-Based
Strand Displacement Activation
Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture
Immunoassays
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
D. Personal Testing
E. Worldwide Business Environment
F. Worldwide Market Structure
G. Worldwide Market Size and Growth
France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Affymetrix
Beckman Coulter
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
J&J Diagnostics
Kreatech
Life Technology
Lonza
Nanogen
Novartis Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako
List of Tables
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Worldwide All Market Segments Laboratories Performing Infectious Disease
Tests by Country
Worldwide All Market Segments Total Infectious Disease Test Volume
Forecast by Country
Worldwide All Market Segments Total Infectious Disease Diagnostics Market
Forecast by Country
Infectious Disease Tests Major Issues and Market Potential For Personal
Testing
France Summary Table All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
France Laboratories Performing Infectious Disease Tests by Market Segment
France Hospital Laboratories Performing Infectious Disease Tests by Bed
Size
France Commercial/Private Laboratories Performing Infectious Disease Tests
by Annual Test Volume
France All Market Segments Infectious Disease Test Volume Forecast
France Hospital Laboratories Infectious Disease Test Volume Forecast
France Blood Banks Infectious Disease Test Volume Forecast
France Commercial/Private Laboratories Infectious Disease Test Volume
Forecast
France All Market Segments Infectious Disease Diagnostics Market Forecast
France Hospital Laboratories Infectious Disease Diagnostics Market Forecast
France Blood Banks Infectious Disease Diagnostics Market Forecast
France Commercial/Private Laboratories Infectious Disease Diagnostics
Market Forecast
France HIV or HIVI/HIVII Test Volume and Diagnostics Sales Forecast
Forecast by Market Segment
France HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast
by Market Segment
France HIV Ag Test Volume and Diagnostics Sales Forecast by Market Segment
France Western Blot/Other Confirmatory Test Volume and Diagnostics Sales
Forecast by Market Segment
France Adenovirus Test Volume and Diagnostics Sales Forecast by Market
Segment
France Aeromonads Test Volume and Diagnostics Sales Forecast by Market
Segment
France BEA Test Volume and Diagnostics Sales Forecast by Market Segment
France Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by
Market Segment
France Campylobacter Test Volume and Diagnostics Sales Forecast by Market
Segment
France Candida Test Volume and Diagnostics Sales Forecast by Market Segment
France Chancroid Test Volume and Diagnostics Sales Forecast by Market
Segment
France Chlamydia Test Volume and Diagnostics Sales Forecast by Market
Segment
France Clostridium Test Volume and Diagnostics Sales Forecast by Market
Segment
France Coronavirus Test Volume and Diagnostics Sales Forecast by Market
Segment
France Coxsackievirus Test Volume and Diagnostics Sales Forecast by Market
Segment
France Cryptosporidium Test Volume and Diagnostics Sales Forecast by
Market Segment
France CMV Test Volume and Diagnostics Sales Forecast by MarketSegment
France Cyclospora Test Volume and Diagnostics Sales Forecast by Market
Segment
France E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
France Echovirus Test Volume and Diagnostics Sales Forecast by Market
Segment
France Encephalitis Test Volume and Diagnostics Sales Forecast by Market
Segment
France Enterovirus Test Volume and Diagnostics Sales Forecast by Market
Segment
France EBV Test Volume and Diagnostics Sales Forecast by Market Segment
France Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
France Gonorrhea Test Volume and Diagnostics Sales Forecast by Market
Segment
France Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by
Market Segment
France Hantavirus Test Volume and Diagnostics Sales Forecast by Market
Segment
France Helicobacter Pylori Test Volume and DiagnosticsSales Forecast by
Market Segment
France HBsAg Test Volume and Diagnostics Sales Forecast by Market Segment
France Hepatitis C Test Volume and Diagnostics Sales Forecast by Market
Segment
France Anti-HBc Test Volume and Diagnostics Sales Forecast by Market
Segment
France Anti-HBs Test Volume and Diagnostics Sales Forecast by Market
Segment
France Anti-HAV Test Volume and Diagnostics Sales Forecast by Market
Segment
France Hepatitis Delta Test Volume and Diagnostics Sales Forecast by
Market Segment
France HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
France HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
France HBcAg Test Volume and Diagnostics Sales Forecastby Market Segment
France HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
France ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market
Segment
France Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast
by Market Segment
France Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market
Segment
France Influenza Test Volume and Diagnostics Sales Forecast by Market
Segment
France Legionella Test Volume and Diagnostics Sales Forecast by Market
Segment
France Lyme Disease Test Volume and Diagnostics Sales Forecast by Market
Segment
France Lymphogranuloma Test Volume and Diagnostics Sales Forecast by
Market Segment
France Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
France Measles Test Volume and Diagnostics Sales Forecast by Market Segment
France Meningitis Test Volume and Diagnostics Sales Forecast by Market
Segment
France Microsporidium Test Volume and Diagnostics Sales Forecast by Market
Segment
France Mononucleosis Test Volume and Diagnostics Sales Forecast by Market
Segment
France Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
France Mycoplasma Test Volume and Diagnostics Sales Forecast by Market
Segment
France Papilloma Virus Test Volume and Diagnostics Sales Forecast by
Market Segment
France Parvovirus Test Volume and Diagnostics Sales Forecast by Market
Segment
France Pneumonia Test Volume and Diagnostics Sales Forecast by Market
Segment
France Polyoma Viruses Test Volume and Diagnostics Sales Forecast by
Market Segment
France Pseudomonas Test Volume and Diagnostics Sales Forecast by Market
Segment
France Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
France RSV Test Volume and Diagnostics Sales Forecast by Market Segment
France Rhinovirus Test Volume and Diagnostics Sales Forecast by Market
Segment
France Rotavirus Test Volume and Diagnostics Sales Forecast by Market
Segment
France Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
France Salmonella Test Volume and Diagnostics Sales Forecast by Market
Segment
France Septicemia Test Volume and Diagnostics Sales Forecast by Market
Segment
France Shigella Test Volume and Diagnostics Sales Forecast by Market
Segment
France Staphylococci Test Volume and Diagnostics Sales Forecast by Market
Segment
France Streptococci Test Volume and Diagnostics Sales Forecast by Market
Segment
France Syphilis Test Volume and Diagnostics Sales Forecast by Market
Segment
France Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market
Segment
France Trichomonas Test Volume and Diagnostics Sales Forecast by Market
Segment
France Tuberculosis Test Volume and Diagnostics Sales Forecast by Market
Segment
France Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
France Yersinia Test Volume and Diagnostics Sales Forecast by Market
Segment
France AIDS Testing Market Diagnostics Sales by Major Supplier
France Adenovirus Testing Market Diagnostics Sales by Major Supplier
France Campylobacter Testing Market Diagnostics Sales by Major Supplier
France Candida Testing Market Diagnostics Sales by Major Supplier
France Chlamydia Testing Market Diagnostics Sales by Major Supplier
France CMV Testing Market Diagnostics Sales by Major Supplier
France Gonorrhea Testing Market Diagnostics Sales by Major Supplier
France Hepatitis Testing Market Diagnostics Sales by Major Supplier
France Hepatitis C Testing Market Diagnostics Sales by Major Supplier
France Herpes Testing Market Diagnostics Sales by Major Supplier
France Lyme Disease Testing Market Diagnostics Sales by Major Supplier
France Influenza Testing Market Diagnostics Sales by Major Supplier
France Meningitis Testing Market Diagnostics Sales by Major Supplier
France Mononucleosis Testing Market Diagnostics Sales by Major Supplier
France Mumps Testing Market Diagnostics Sales by Major Supplier
France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
France RSV Testing Market Diagnostics Sales by Major Supplier
France Rotavirus Testing Market Diagnostics Sales by Major Supplier
France Rubella Testing Market Diagnostics Sales by Major Supplier
France Septicemia Testing Market Diagnostics Sales by Major Supplier
France Shigella Testing Market Diagnostics Sales by Major Supplier
France Streptococci Testing Market Diagnostics Sales by Major Supplier
France Syphilis Testing Market Diagnostics Sales by Major Supplier
France Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
France Trichomonas Testing Market Diagnostics Sales by Major Supplier
France Tuberculosis Testing Market Diagnostics Sales by Major Supplier
France Infectious Disease Diagnostic Testing Instrumentation Major Systems
Estimated Placements and Installed Base
French Microbiology Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers published by Venture Planning Group in May 17, 2013. This report price starts from US $ 4300.
The contents of this page may be different from the latest version. Please contact us for details.
